We are live on ! Find out more
DRD

Dennis R. Delaney Portfolio holdings

AUM $282M
1-Year Est. Return 16.32%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+16.32%
3 Year Est. Return
+57.02%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$200M
AUM Growth
+$4.92M
Cap. Flow
-$4.4M
Cap. Flow %
-2.2%
Top 10 Hldgs %
47.44%
Holding
50
New
1
Increased
9
Reduced
27
Closed
1

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$833K
2
SCHW
Charles Schwab
SCHW
+$690K
3
UBER icon
Uber
UBER
+$636K
4
AXP icon
American Express
AXP
+$512K
5
LLY icon
Eli Lilly
LLY
+$252K

Top Sells

Rank Stock Value
1
MKC icon
McCormick & Company Non-Voting
MKC
+$845K
2
ROK icon
Rockwell Automation
ROK
+$841K
3
NVDA icon
NVIDIA
NVDA
+$698K
4
AMD icon
Advanced Micro Devices
AMD
+$588K
5
MA icon
Mastercard
MA
+$575K

Sector Composition

Rank Sector Weight
1 Technology 33.32%
2 Healthcare 19.04%
3 Industrials 13.2%
4 Consumer Discretionary 10.91%
5 Financials 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$123B
$2.76M 1.38%
7,048
-295
-4% -$123K
UNH icon
27
UnitedHealth
UNH
$388B
$2.6M 1.3%
7,532
-1,364
-15% -$413K
UBER icon
28
Uber
UBER
$141B
$2.09M 1.05%
21,348
+6,798
+47% +$636K
SCHW
29
Charles Schwab
SCHW
$184B
$1.89M 0.95%
19,765
+7,265
+58% +$690K
AXP icon
30
American Express
AXP
$227B
$1.71M 0.86%
5,153
+1,611
+45% +$512K
LLY icon
31
Eli Lilly
LLY
$1.09T
$1.69M 0.85%
2,216
+338
+18% +$252K
CRM icon
32
Salesforce
CRM
$150B
$1.66M 0.83%
7,005
-97
-1% -$24.5K
MKC icon
33
McCormick & Company Non-Voting
MKC
$13.8B
$1.49M 0.75%
22,270
-12,065
-35% -$845K
AMAT icon
34
Applied Materials
AMAT
$379B
$1.37M 0.69%
6,683
+4,592
+220% +$833K
NSC icon
35
Norfolk Southern
NSC
$76.9B
$1.19M 0.59%
3,953
– –
NVO
36
Novo Nordisk
NVO
$225B
$1.18M 0.59%
21,270
-5,440
-20% -$318K
PEP icon
37
PepsiCo
PEP
$194B
$750K 0.38%
5,340
-165
-3% -$23.6K
UNP icon
38
Union Pacific
UNP
$177B
$409K 0.21%
1,732
– –
GIS icon
39
General Mills
GIS
$20.1B
$403K 0.2%
8,000
– –
BRK.B icon
40
Berkshire Hathaway Class B
BRK.B
$1.1T
$400K 0.2%
795
– –
NEE icon
41
NextEra Energy
NEE
$188B
$384K 0.19%
5,090
– –
HON icon
42
Honeywell
HON
$78.4B
$284K 0.14%
1,432
-53
-4% -$11.1K
BALL icon
43
Ball Corp
BALL
$17.7B
$264K 0.13%
5,230
-10,335
-66% -$559K
BBAI icon
44
BigBear.ai
BBAI
$1.35B
$156K 0.08%
24,000
– –
IOVA icon
45
Iovance Biotherapeutics
IOVA
$2.13B
$82.5K 0.04%
38,000
– –
CLLS
46
Cellectis
CLLS
$282M
$68.4K 0.03%
+24,000
New +$62.2K
AUTL
47
Autolus Therapeutics
AUTL
$383M
$39.1K 0.02%
24,000
– –
NVS icon
48
Novartis
NVS
$303B
– –
-1,725
Closed -$209K
1
2

Similar funds

WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
TC
TAGStone Capital Charlotte, North Carolina $283M AUM 14.51% 1-Year Est. Return
UFAC
Urban Financial Advisory Corp Chicago, Illinois $283M AUM 13.45% 1-Year Est. Return
DIP
Davis Investment Partners Charlotte, North Carolina $283M AUM 24.98% 1-Year Est. Return
3CP
3G Capital Partners New York $282M AUM 22.21% 1-Year Est. Return
MFG
Monte Financial Group Guilford, Connecticut $282M AUM 14.97% 1-Year Est. Return
BO
Bank OZK Little Rock, Arkansas $283M AUM 24.45% 1-Year Est. Return
BA
Bluesphere Advisors East Norriton, Pennsylvania $281M AUM 23.95% 1-Year Est. Return

Dennis R. Delaney's Q3 2025 Portfolio in Review

As of Q3 2025, Dennis R. Delaney held 50 positions worth $200M, up 2.5% from $195M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 4%. Dennis R. Delaney opened 1 new position and exited 1, leaving the 50-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

  • Dennis R. Delaney's largest Q3 2025 buy was Cellectis: 24,000 shares worth $68.4K.
  • Dennis R. Delaney added most to Applied Materials in Q3 2025, an estimated $833K increase.
  • Dennis R. Delaney's biggest Q3 2025 reduction was McCormick & Company Non-Voting, cutting an estimated $845K.
  • Dennis R. Delaney fully exited Novartis in Q3 2025, selling an estimated $209K.
  • Dennis R. Delaney's ten largest holdings make up 47% of its $200M portfolio in Q3 2025.
  • Dennis R. Delaney opened 1 new position and closed 1 in Q3 2025.
  • Dennis R. Delaney's portfolio value rose 2.5% quarter-over-quarter to $200M.

Based on Dennis R. Delaney's 13F filing for Q3 2025, filed 10 Nov 2025.